Company: BIAF
Filing Date: 2025-05-05
Form Type: S-1/A
Source: 0001641172-25-008629
Chunk: 174

Company: bioAffinity Technologies, Inc.
Filing Date: 2025-05-05
Form: S-1/A
Chunk 174
---
 provided that any increase in the beneficial ownership limitation shall not be effective until 61 days following notice to us.

Cashless Exercise

If, at the time after the date of issuance of the May 2025 Warrants and the date of Warrant Stockholder Approval, a holder exercises its May 2025 Warrants and a registration statement registering the issuance of the shares of Common Stock underlying the May 2025 Warrants under the Securities Act is not then effective or available for the issuance of such shares, then in lieu of making the cash payment otherwise contemplated to be made to us upon such exercise in payment of the aggregate exercise price, the holder may elect instead to receive upon such exercise (either in whole or in part) the net number of shares of Common Stock determined according to a formula set forth in the May 2025 Warrants, provided however that those purchasers who do not enter into the Purchase Agreement and do not provide us with information required for registration of the shares of Common Stock to be issued upon an Anti-Dilution Adjustment shall not be able to effect a cashless exercise with respect to Warrant Shares issuable upon the triggering of the Anti-Dilution Adjustment.

| 82 |

Fractional Shares

No fractional shares of Common Stock will be issued upon the exercise of the May 2025 Warrants. Rather, the number of shares of Common Stock to be issued will be rounded up to the next whole share or we will pay a cash adjustment equal to such fraction multiplied by the exercise price to the holder.

Transferability

Subject to applicable laws, a warrant may be transferred at the option of the holder upon surrender of the warrant to us together with the appropriate instruments of transfer.

Trading Market

There is no trading market available for the May 2025 Warrants on any securities exchange or nationally recognized trading system, and we do not expect a trading market to develop. We do not intend to list the May 2025 Warrants on any securities exchange or other trading market. Without a trading market, the liquidity of the May 2025 Warrants will be extremely limited. The Common Stock issuable upon exercise of the May 2025 Warrants is currently listed on the Nasdaq Capital Market.

Rights as a Stockholder

Except as otherwise provided in the May 2025 Warrants or by virtue of such holder’s ownership of shares of our Common Stock, the holders of the May 2025 Warrants do not have the rights or privileges of holders of our Common Stock, including any voting rights, until they exercise